BioCentury
ARTICLE | Product Development

Informed optimism

May 29, 2006 7:00 AM UTC

Cancer immunotherapy has been in the doghouse of ideas for years, based on the failure of clinical trials too numerous to count. As a result, attitudes toward the concept have swung from unbridled enthusiasm to deep despair.

The upcoming meeting of the American Society of Clinical Oncology on June 2-6 in Atlanta may begin to change views, as it opens a stretch of clinical milestones that should make 2006 an important year for these therapies...